Fc Receptor and IgG Targeted Therapies Conference (ATXS)

As hyper-specific as the event might sound, the options on ATXS are suggesting an implied volatility of +/-20% or more (as of April 21, will update as the event gets closer). Due to the lower visibility of this event, the “runup period” could be less volatile than other runup periods for more widely known events. Which could create an opportunity for traders to make a short term trade, bookending the event and capturing gains from the possible increased interest stemming from their presentation.

From what our research shows, there are no other publicly traded companies presenting at this event.

To learn more about the data being presented and the event, this is the link to the Event Website: https://fcr-targeted-therapies.com/